87. Osio A, Deslandes E, Saada V, et al.
Clinical charac-
teristics of molluscum contagiosum in children in
a private dermatology practice in the greater Paris
area, France: a prospective study in 661 patients.
Dermatology. 2011;222(4):314-320.
88. Luke JD, Silverberg NB. Vertically transmitted mol-
luscum contagiosum infection. Pediatrics. 2010;
125(2):e423-e425.
89. Berbegal-DeGracia L, Betlloch-Mas I, DeLeon-Marrero
F-J, et al. Neonatal molluscum contagiosum: five new
cases and a literature review. Australas J Dermatol.
2015;56(2):e35-e38.
90. Chen X, Anstey AV, Bugert JJ. Review molluscum
contagiosum virus infection. Lancet Infect Dis. 2013;
13(10):877-888.
91. Petersen CS, Gerstoft J. Molluscum contagiosum in HIV-
infected patients. Dermatology. 1992;184(1):19-21.
92. Berger EM, Orlow SJ, Patel RR, et al. Experience with
molluscum contagiosum and associated inflamma-
tory reactions in a pediatric dermatology practice.
Arch Dermatol. 2012;148(11):1257-1258.
93. Smith KJ, Col, Usa MC, et al. Molluscum contagiosum:
its clinical, histopathologic, and immunohistochemi-
cal spectrum. Int J Dermatol. 1999;38(9):664-672.
94. Senkevich TG, Koonin EV, Bugert JJ, et al. The
genome of molluscum contagiosum virus: analy-
sis and comparison with other poxviruses. Virology.
1997;233(1):19-42.
95. Braue A, Ross G, Varigos G, et al. Epidemiology and
impact of childhood molluscum contagiosum: a case
series and critical review of the literature. Pediatr
Dermatol. 2005;22(4):287-294.
96. Shisler JL. Immune evasion strategies of molluscum
contagiosum virus. Adv Virus Res. 2015;92:201-252.
97. Vermi W, Fisogni S, Salogni L, et al. Spontaneous
regression of highly immunogenic molluscum con-
tagiosum virus (MCV)-induced skin lesions Is associ-
ated with plasmacytoid dendritic cells and IFN-DC
infiltration. J Invest Dermatol. 2011;131(2):426-434.
98. Olsen JR, Gallacher J, Piguet V, et al. Epidemiology
of molluscum contagiosum in children: a systematic
review. Fam Pract. 2014;31(2):130-136.
99. Dohil MA, Lin P, Lee J, et al. The epidemiology of mol-
luscum contagiosum in children. J Am Acad Dermatol.
2006;54(1):47-54.
100. Olsen JR, Piguet V, Gallacher J, et al. Molluscum con-
tagiosum and associations with atopic eczema in
children: a retrospective longitudinal study in pri-
mary care. Br J Gen Pract. 2015;66(642):e53-e58.
101. Seize MB, Ianhez M, Cestari Sda C. A study of the
correlation between molluscum contagiosum and
atopic dermatitis in children. An Bras Dermatol.
2011;86(4):663-668.
102. Martin P. Interventions for molluscum contagio-
sum in people infected with human immunode-
ficiency virus: a systematic review. Int J Dermatol.
2016;55(9):956-966.
103. Maurer T, Rodrigues LK, Ameli N, et al. The effect of
highly active antiretroviral therapy on dermatologic
disease in a longitudinal study of HIV type 1-infected
women. Clin Infect Dis. 2004;38(4):579-584.
104. Drain PK, Mosam A, Gounder L, et al. Recurrent giant
molluscum contagiosum immune reconstitution
inflammatory syndrome (IRIS) after initiation of anti-
retroviral therapy in an HIV-infected man. Int J STD
AIDS. 2014;25(3):235-238.
105. Chu EY. Cutaneous manifestations of DOCK8 defi-
ciency syndrome. Arch Dermatol. 2012;148(1):79-15.
booksmedicos.org
Kang_CH166_p3065-3094.indd 3093
106. Beutler BD, Cohen PR. Molluscum contagiosum of
the eyelid: case report in a man receiving methotrex-
25
ate and literature review of molluscum contagiosum
in patients who are immunosuppressed secondary
to methotrexate or HIV infection. Dermatol Online J.
2016;22(3).
107. Kinoshita M, Ogawa Y, Kawamura T, et al. Case of dis-
seminated molluscum contagiosum caused by rux-
olitinib, a Janus kinase 1 and 2 inhibitor. J Dermatol.
2016;43(11):1387-1388.
108. Behle V, Wobser M, Goebeler M, et al. Extensive
molluscum contagiosum virus infection in a young
adult receiving fingolimod. Mult Scler. 2016;22(7):
969-971.
109. Morales A, Puig S, Malvehy J, et al. Dermoscopy
of molluscum contagiosum. Arch Dermatol. 2005;
Chapter 166 :: Poxvirus Infections
141(12):1644-1644.
110. Vazquez-Lopez F, Kreusch J, Marghoob AA.
Dermoscopic semiology: further insights into vascu-
lar features by screening a large spectrum of nontu-
moral skin lesions. Br J Dermatol. 2004;150(2):226-231.
111. Ianhez M, Cestari Sda C, Enokihara MY, et al.
Dermoscopic patterns of molluscum contagiosum: a
study of 211 lesions confirmed by histopathology. An
Bras Dermatol. 2011;86(1):74-79.
112. Olsen JR, Gallacher J, Finlay AY, et al. Time to reso-
lution and effect on quality of life of molluscum
contagiosum in children in the UK: a prospective
community cohort study. Lancet Infect Dis. 2015;15(2):
190-195.
113. McCuaig C, Silverberg N, Santer M. Commentaries on
“Interventions for cutaneous molluscum contagio-
sum.” Evid Based Child Health. 2011;6(5):1602-1605.
114. van der Wouden JC, van der Sande R, Kruithof EJ, et al.
Interventions for cutaneous molluscum contagio-
sum. Cochrane Database Syst Rev. 2017; (5):CD004767.
115. Coloe J, Morrell DS. Cantharidin use among pediatric
dermatologists in the treatment of molluscum conta-
giosum. Pediatr Dermatol. 2009;26(4):405-408.
116. Griffith RD, Yazdani Abyaneh M-A, Falto-Aizpurua L,
et al. Pulsed dye laser therapy for molluscum conta-
giosum: a systematic review. J Drugs Dermatol. 2014;
13(11):1349-1352.
117. Coloe Dosal J, Stewart PW, Lin J-A, et al. Cantharidin
for the treatment of molluscum contagiosum: a pro-
spective, double-blinded, placebo-controlled trial.
Pediatr Dermatol. 2014;31(4):440-449.
118. Mathes EF, Frieden IJ. Treatment of molluscum con-
tagiosum with cantharidin: a practical approach.
Pediatr Ann. 2010;39(3):124-128, 130.
119. Moed L, Shwayder TA, Chang MW. Cantharidin revis-
ited: a blistering defense of an ancient medicine. Arch
Dermatol. 2001;137(10):1357-1360.
120. Silverberg NB, Sidbury R, Mancini AJ. Childhood
molluscum contagiosum: experience with canthari-
din therapy in 300 patients. J Am Acad Dermatol.
2000;43(3):503-507.
121. Osier E, Eichenfield LF. The utility of cantharidin for
the treatment of molluscum contagiosum. Pediatr
Dermatol. 2015;32(2):295-296.
122. Moye VA, Cathcart S, Morrell DS. Safety of cantharidin:
a retrospective review of cantharidin treatment in
405 children with molluscum contagiosum. Pediatr
Dermatol. 2014;31(4):450-454.
123. Cathcart S, Coloe J, Morrell DS. Parental satisfaction,
efficacy, and adverse events in 54 patients treated
with cantharidin for molluscum contagiosum 3093
infection. Clin Pediatr (Phila). 2008;48(2):161-165.
08/12/18 4:52 pm